The causes for coronary sinus injury were procedural, taking place early in the trial, and changes were made in technique for subsequent implants. Interestingly, coronary arteries were crossed in ...

The duo cited a hypothesis that coronary sinus reducer therapy helps "collateral ... market for over a decade for people with chest pain and no other options for revascularization.

Inter-atrial shunt device therapy has shown mixed results in clinical trials, with clinical 'non-responders' typically showing features of more advanced heart failure. We aimed to analyse the ...

With the retrograde cardioplegia cannula, the solution is perfused through the coronary sinus. The MAQUET retrograde cardioplegia cannula is used for perfusing cardioplegic solutions via the ...